Search Tips
Home |
Publications |
Custom Books and Slides |
News and Events |
Tools and Resources |
Browse |
My DCPP

Home  >  Browse by Topic  > 

Economics and Cost-Effectiveness

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)
  1. 25. Acute Respiratory Infections in Children
    1. Conclusions: Promises and Pitfalls
    2. Cost-Effectiveness of Interventions
    3. Interventions
    4. Research and Development Agenda
  2. 59. Adolescent Health Programs
    1. Conclusions
    2. Costs and Cost-Effectiveness of Interventions
    3. Economic Analysis
    4. Interventions
    5. Nature and Causes of the Burden of Disease in Young People
    6. Program Implementation and Lessons of Experience
    7. Research and Development Agenda
  3. 43. Air and Water Pollution: Burden and Strategies for Control
    1. Conclusion: Promises and Pitfalls
    2. Economic Benefits of Interventions
    3. Implementation of Control Strategies: Lessons of Experience
    4. Intervention Costs and Cost-Effectiveness
    5. Interventions
    6. Nature, Causes, and Burden of Air and Water Pollution
    7. Research and Development Agenda
  4. 47. Alcohol
    1. Conclusion
    2. Cost-Effectiveness of Interventions
    3. Economic Benefits of Interventions
    4. Epidemiology of Alcohol Use and Alcohol-Related Disease Conditions
    5. Interventions for Reducing High-Risk Drinking
    6. Research and Development Agenda
  5. 33. Cardiovascular Disease
    1. Burden of Disease
    2. Conclusions: Pitfalls and Promises
    3. Cost-Effectiveness of Interventions
    4. Research and Development
  6. 56. Community Health and Nutrition Programs
    1. Contextual Factors
    2. Future Applications
    3. Programmatic Factors
    4. Research Needs
    5. Results
    6. What Is Known about Efficacy and Effectiveness
  7. 69. Complementary and Alternative Medicine
    1. Economics of Complementary and Alternative Medicine and Traditional Medicine
    2. Expanding the Beneficial Use of Complementary and Alternative Medicine and Traditional Medicine
  8. 21. Conquering Malaria
    1. Economics of Malaria Control Interventions
    2. Interventions and Their Effectiveness
    3. Research Priorities
  9. 57. Contraception
    1. Economic Benefits of Intervention
    2. Intervention Cost and Cost-Effectiveness
    3. Nature, Causes, and Burden of the Conditions That Can Be Addressed
    4. Organization of Family-Planning Programs
    5. Research and Development Agenda
  10. 15. Cost–Effectiveness Analysis for Priority Setting
    1. Acknowledgments
    2. Cost-Effectiveness and Population Impact
    3. Cost-Effectiveness and Priority Setting
    4. Definition and Characteristics of Interventions
    5. Determining Costs for Interventions
    6. Estimating Effectiveness in Health
    7. Improvements and Further Applications
    8. More and Less Comprehensive Data and Analysis
  11. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
    1. Acknowledgments
    2. Burden of Musculoskeletal Disease
    3. Conclusions: Promises and Pitfalls
    4. Cost-Effectiveness of Interventions for OA
    5. Cost-Effectiveness of Interventions for Other Musculoskeletal Conditions
    6. Cost-Effectiveness of Interventions for RA
    7. Economic Issues
    8. Implementation of Control Strategies: Lessons of Experience
    9. Nature, Causes, and Epidemiology of Musculoskeletal Conditions
    10. Preventive Strategies
    11. Research and Development
    12. Treatments
  12. 30. Diabetes: The Pandemic and Potential Solutions
    1. Conclusions
    2. Cost-Effectiveness of Interventions and Priorities
    3. Lessons and Experience
    4. Nature and Distribution of Diabetes
    5. Research and Development Agenda
  13. 19. Diarrheal Diseases
    1. Cost-Effectiveness of Interventions
    2. Preventive Strategies
    3. Public Health Significance of Diarrheal Illnesses
    4. Research Agenda
  14. 36. Diseases of the Kidney and the Urinary System
    1. Economic Benefits of Intervention
    2. Global Perspectives in Relation to RRT
    3. Research and Development Agenda
  15. 55. Drug Resistance
    1. Agenda for Action
    2. Economic Burden
    3. Implementation of Strategies: Two Lessons from Experience
    4. Interventions
  16. 7. Economic Approaches to Valuing Global Health Research
    1. Methods of Assessing the Value of Health Research Projects
    2. The Value of Health Research
  17. 68. Emergency Medical Services
    1. Interventions for Emergency Care: Systems, Structures, and Organization
    2. The Research and Development Agenda
  18. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
    1. Procurement of Drugs
    2. Selection of Drugs
    3. Vaccine Research Priorities
  19. 14. Ethical Issues in Resource Allocation, Research, and New Product Development
    1. Health Resource Allocation
  20. 12. Financing Health Systems in the 21st Century
    1. Absorption, Effectiveness, and Sustainability of Donor Funds
    2. Conclusions
    3. Health Financing Issues in LICs
    4. Health Financing Issues in MICs
    5. Health Financing Systems
  21. 11. Fiscal Policies for Health Promotion and Disease Prevention
    1. Subsidies for Health and Health-Related Products
    2. Use of Fiscal Policy for Health in Developing Countries
  22. 10. Gender Differentials in Health
    1. Conclusions
    2. Cost-Effectiveness of Interventions
    3. Priority Disease Groups for Women
    4. Research Agenda
  23. 64. General Primary Care
    1. A Research and Development Agenda for General Primary Care
    2. Conclusions
    3. Scaling Up
    4. The Cost-Effectiveness of Primary Care Interventions
    5. The Effectiveness of General Primary Care
    6. The Scope of General Primary Care Practice
  24. 29. Health Service Interventions for Cancer Control in Developing Countries
    1. Applicability of Cost-Effectiveness Studies from Developed to Developing Countries
    2. Conclusions
    3. Cost-Effectiveness of Cancer Control Interventions
    4. Research Agenda
  25. 71. Health Workers: Building and Motivating the Workforce
    1. Advice for Governments
    2. Health Care Provision and Associated Human Resource Needs
    3. Health Worker Incentives
  26. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
    1. Conclusions: Promises and Pitfalls
    2. Cost-Effectiveness Analysis of Interventions
    3. Economic Benefits of Intervention
    4. Implementation of Control Strategies: Lessons of Experience
    5. Research and Development
  27. 18. HIV/AIDS Prevention and Treatment
    1. Action under Uncertainty
    2. Care and Treatment
    3. Prevention in Theory and Practice: Using Epidemic Profiles and Contextual Factors to Inform Prevention Guidelines
  28. 48. Illicit Opiate Abuse
    1. Conclusions: Promises and Pitfalls
    2. Interventions for Illicit Opioid Dependence
    3. Nature, Causes, and Health Consequences of Illicit Opioid Use
  29. 8. Improving the Health of Populations: Lessons of Experience
    1. Conclusion
    2. General Findings
    3. Intervention Type, Programmatic Characteristics, and Policies
    4. Research Methods
  30. 70. Improving the Quality of Care in Developing Countries
    1. Conclusion
    2. Economic Benefits and Costs of Quality Care
    3. Measuring Quality
    4. Policy Interventions to Improve Quality
    5. Research Agenda on Quality
  31. 42. Indoor Air Pollution
    1. Conclusions
    2. Implementation of Control Strategies: Lessons from Experience
    3. Intervention Costs and Effectiveness
    4. Nature, Causes, and Burden of Condition
    5. The Research and Development Agenda
  32. 54. Information to Improve Decision Making for Health
    1. Benefits, Costs, and Cost-Effectiveness of Improved Information
    2. Financing of Improved Health Information
    3. Research and Development
    4. Systems and Supply of Health Information
  33. 34. Inherited Disorders of Hemoglobin
    1. Conclusions
    2. Costs and Effectiveness of Diagnosis and Management
    3. Options for Control and Management of Inherited Hemoglobin Disorders
  34. 63. Integrated Management of the Sick Child
    1. Acknowledgments
    2. Conclusions: Promises and Pitfalls
    3. Intervention Cost and Cost-Effectiveness
    4. Nature, Causes, and Burden of Child Mortality
    5. The Research and Development Agenda
  35. 40. Interpersonal Violence
    1. Conclusions: Promises and Pitfalls
    2. Cost-Effectiveness of Interventions
    3. Economic Impact of Violence
    4. Implementation of Prevention Strategies
    5. The Nature, Burden, and Causes of Interpersonal Violence
  36. 2. Intervention Cost–Effectiveness: Overview of Main Messages
    1. Annex 2.A: Intervention Categories and Pertinent Policy Instruments
    2. Annex 2.C: Summary of other Interventions
    3. Assessing the Evidence on the Cost-Effectiveness of Interventions
    4. Discussion
    5. Methodology
    6. Priority Setting
  37. 1. Investing in Health
    1. Annex 1.A: The Burden of Disease in 2001
    2. Child Health
    3. Conclusions
    4. Development Assistance for Health
    5. Health System Development and Finance
    6. Noncommunicable Disease and Injury
    7. The 20th Century Takeoff in Human Health
    8. The Economic Benefits of Better Health
    9. Why Has Mortality Declined at Such Different Rates in Different Countries?
  38. 49. Learning and Developmental Disabilities
    1. Interventions in Low- and Middle-Income Countries
    2. Research Agenda for Prevention of Disabilities in Low- and Middle-Income Countries
    3. Summary
  39. 50. Loss of Vision and Hearing
    1. Conclusions: Promises and Pitfalls
    2. Nature, Causes, and Epidemiology of Hearing Loss
    3. Nature, Causes, and Epidemiology of Vision Loss
    4. Research and Development Agenda
  40. 26. Maternal and Perinatal Conditions
    1. Acknowledgments
    2. Annex 26.A: CEA Model Assumptions
    3. Conclusions
    4. Cost-Effectiveness of Selected Intervention Packages
    5. Economic Benefits of Intervention
    6. Epidemiology of Maternal and Perinatal Conditions
    7. Interventions
    8. Lessons for Implementation
    9. Research and Development Needs
  41. 31. Mental Disorders
    1. Anxiety Disorders
    2. Conclusion: Public Support for a Cost-Effective Intervention Package
    3. Cost-Effectiveness Methods and Results
    4. Mood Disorders
    5. Policy and Service Implications
    6. Schizophrenia and Nonaffective Psychoses
  42. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
    1. Costing and Financing Additional Spending for the MDGs
    2. What Do Countries Need To Do?
  43. 61. Natural Disaster Mitigation and Relief
    1. Acknowledgments
    2. Conclusions
    3. Disasters as a Public Health Condition
    4. Intervention Cost, Cost-Effectiveness, and Economic Benefits
    5. Interventions: From Response to Prevention
    6. The Research and Development Agenda
  44. 32. Neurological Disorders
    1. AD and Other Dementias
    2. Cost-Effectiveness of Interventions in Developing Countries
    3. Epilepsy
    4. Parkinson's Disease
    5. Recommendations
  45. 27. Newborn Survival
    1. Implementation
    2. Interventions
    3. Marginal Impact and Cost of Scaling Up Universal Neonatal Packages
    4. Research Priorities
  46. 60. Occupational Health
    1. Conclusions
    2. Economic Aspects of Intervention
    3. Global Burden of Disease from Occupational Health Risks
    4. Implementation
    5. Interventions
  47. 38. Oral and Craniofacial Diseases and Disorders
    1. Aspects of Treatment of Cavities and of Caries Disease
    2. Cost-Effectiveness of Oral Health Care
    3. Dental Caries
  48. 52. Pain Control for People with Cancer and AIDS
    1. Costs and Cost-Effectiveness
    2. Implementation of Strategies to Improve Pain Control
    3. Recommendations for Research and Development
  49. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Cost-Effectiveness of Interventions
    2. Interventions
    3. Research and Development Priorities
  50. 4. Priorities for Global Research and Development of Interventions
    1. Key Recommendations
    2. Needs, Context, Opportunities, and Major Challenges
    3. Priority Setting
  51. 6. Product Development Priorities
    1. Diagnostics
    2. Financing and Institutional Arrangements for New Product Development
    3. Intellectual Property
    4. Pharmaceutical Products
    5. Regulatory and Liability Issues
  52. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
    1. Economics of Public Health Surveillance Systems
  53. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Making Development Assistance for Health More Effective: Lessons Learned
    2. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
    3. Trends and Gaps in Development Assistance for Health
  54. 66. Referral Hospitals
    1. Current Balance of Care in Practice
    2. Functions and Benefits
    3. Getting Better Value for Money from the Hospital System
  55. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Future Research Needs
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Occupational Lung Disease and Other Respiratory Diseases
  56. 58. School–Based Health and Nutrition Programs
    1. Conclusions
    2. Cost-Effectiveness of Intervention
    3. Economic Benefits of Intervention
    4. Estimating the Burden of Disease
    5. Implementation of Programs and Lessons from Experience
    6. Interventions
    7. Research and Development Agenda
  57. 5. Science and Technology for Disease Control: Past, Present, and Future
    1. Science, Technology, and Medicine in the 20th Century
    2. Science, Technology, and Medicine in the Future
  58. 17. Sexually Transmitted Infections
    1. Bacterial and Viral STIs and Their Sequelae
    2. Conclusions
    3. Intervention Costs and Cost-Effectiveness
    4. Introduction
    5. Research and Development Agenda
  59. 37. Skin Diseases
    1. Economic Assessments and Skin Diseases in Developing Countries
    2. Skin Diseases
  60. 73. Strategic Management of Clinical Services
    1. The Specifics: What Works?
    2. What Is Management?
  61. 3. Strengthening Health Systems
    1. Assessment of Approaches to Strengthen Health System Capacity
    2. Targeting Resources
  62. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Conclusions
    2. Economic Benefits of Intervention
    3. Intervention Costs and Cost-Effectiveness
    4. Interventions
    5. Nature, Causes, and Burden of Undernutrition
    6. Program Implementation: Lessons of Experience
    7. Research and Development Agenda
  63. 67. Surgery
    1. Conclusions
    2. Costs and Cost-Effectiveness of Interventions
    3. Interventions
    4. Nature, Causes, and Burden of Surgical Conditions
    5. Research and Development Agenda
  64. 65. The District Hospital
    1. Definitions, Basic Concepts, and Framework
    2. Economics of District Hospitals: A Summary of Reported Experience
    3. Effecting Change with Cross-Cutting Interventions
    4. Factors Influencing District Hospitals' Performance
    5. The Future: Research and Information Needs
  65. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
    1. Burden of the Disease, Condition, or Risk Factor
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Economic Benefits of Intervention
    5. Interventions
    6. Research and Development Agenda
  66. 46. Tobacco Addiction
    1. Comprehensive Tobacco-Control Programs
    2. Effectiveness and Cost-Effectiveness of Tobacco-Control Interventions
    3. Interventions to Reduce Demand for Tobacco
    4. Rationale for Government Intervention
  67. 23. Tropical Diseases Lacking Adequate Control Measures: Dengue, Leishmaniasis, and African Trypanosomiasis
    1. Costs and Cost-Effectiveness of Interventions
    2. Disease Burden
    3. Management and Control Strategies
    4. Problems and Challenges for Disease Control
    5. Summary
  68. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
    1. Conclusion
    2. Costs and Cost-Effectiveness of Interventions
    3. Disease Burden
    4. Interventions and Their Effectiveness
  69. 16. Tuberculosis
    1. Acknowledgments
    2. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
    3. Conclusions
    4. Cost-Effectiveness of Interventions against Tuberculosis
    5. Cost-Effectiveness of Managing Endemic Tuberculosis
    6. Cost-Effectiveness of Managing Tuberculosis Outbreaks
    7. Epidemiological Burden and Trends
    8. Interventions against Tuberculosis
    9. Research and Development
    10. Summary of Cost-Effectiveness Analyses
    11. Tuberculosis Infection, Disease, and Death
  70. 39. Unintentional Injuries
    1. Burden and Causes of Unintentional Injuries
    2. Conclusions: Promises and Pitfalls
    3. Costs, Cost-Effectiveness, and Economic Benefits of Intervention
    4. Implementation of Prevention and Control Strategies
    5. Interventions
    6. Research and Development Agenda
  71. 20. Vaccine–Preventable Diseases
    1. Acknowledgments
    2. Causes and Epidemiology of Diseases Prevented by Vaccines Used in National Immunization Programs
    3. Conclusions
    4. Cost-Effectiveness of Increasing Immunization Coverage for the Traditional EPI
    5. Costs and Cost-Effectiveness of Adding New Antigens to the Current Immunization Schedule
    6. Costs and Cost-Effectiveness of Existing Vaccination Programs
    7. Estimates of the Current Burden of Vaccine-Preventable Diseases and of the Burden Averted by Vaccination
    8. Expanded Program on Immunization
    9. Financial Sustainability of Immunization Programs
    10. Improving the Costs and Cost-Effectiveness of Immunization Programs
    11. Research Agenda
  72. 41. Water Supply, Sanitation, and Hygiene Promotion
    1. Effect on Burden of Disease
    2. Excreta Disposal
    3. Hygiene Promotion
    4. Water Supply
Global Burden of Disease and Risk Factors
  1. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
  2. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease
  3. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
    1. Applications of Burden of Disease Analysis
  4. 5. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates
    1. Discounting and Age Weighting in the DALY Measure
  5. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
    1. Quantifying the Global Burden of Disease
Priorities in Health
  1. 1. Accomplishments, Challenges, and Priorities
    1. Accounting for Health Gains
    2. An Agenda for Action
    3. Equity
    4. Putting DCP2 to Use
    5. This Volume
  2. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
    1. Alcohol Abuse
    2. Cancer
    3. Cardiovascular Disease, Diabetes, High Blood Pressure, Cholesterol, and Bodyweight
    4. Conclusion
    5. Congenital and Developmental Disorders
    6. Mental Health
    7. Tobacco Use
    8. Unintentional Injuries
  3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
    1. Infectious and Communicable Diseases
    2. Maternal and Neonatal Health
  4. 3. Cost–Effectiveness Analysis
    1. How Can Policy Makers Use Cost-Effectiveness Analysis?
    2. How Reliable Is Cost-Effectiveness Analysis?
    3. Summary for Using Cost-Effectiveness Analysis Properly
    4. What Are Appropriate Tasks for Cost-Effectiveness Analysis?
    5. What Is Cost-Effectiveness Analysis?
    6. Why Use Cost-Effectiveness Analysis?
  5. 7. Pillars of the Health System
    1. Financing
    2. Human Resources
    3. Information, Surveillance, and Research
    4. Management of Health Services
  6. 6. Providing Interventions
    1. Cross-Level Services and Inputs
    2. Integration of Services Across the Life Cycle
    3. Levels of Care
  7. 2. Success in Addressing Priorities
    1. Conclusion
    2. Cost-Effective Interventions Aimed at Building Health Systems
    3. Cost-Effective Interventions Beyond Health Systems
    4. Cost-Effective Interventions That Furthered Existing Health Systems
    5. Successes Despite Weak Health Systems
    6. Successes That Strengthened Weak Health Systems
  8. 8. The Way Forward: A Blueprint for Action

Conference and Workshop Presentations

  1. Apr 2006, Assessing The Global Burden of Risk Factors: History And Results For 2001 , Beijing, China (PDF | 211.0k)
  2. Jul 2007, Contraception Overview of the DCPP Chapter, Washington, DC, USA (PDF | 4.2MB)
  3. Jul 2006, Control of Non-Communicable Diseases In Sub-Saharan Africa , Arusha, Tanzania (PDF | 385.5k)
  4. Jun 2007, Cost-effectiveness of interventions for reducing the burden of mental disorders and substance abuse (by World Bank region), Washington, DC, USA (PDF | 257.0k)
  5. Apr 2006, HIV/AIDS Prevention and Care , Beijing, China (PDF | 476.5k)
  6. May 2006, How Much Health Can A Million Dollars Buy? , Washington, DC, USA (PDF | 134.1k)
  7. Oct 2006, Investing In Global Health: "Best Buys" And Priorities For Action In Developing Countries , Washington, DC, USA (PDF | 273.5k)
  8. May 2006, Investing in Global Health: Priorities for Action in Developing Countries, Stockholm, Sweden (PDF | 1.4MB)
  9. Jun 2007, Malaria and its Impact on Maternal, Perinatal, and Child Health, Accra, Ghana (PDF | 618.1k)
  10. Jun 2007, New Developments in China's Healthcare Services, Bethesda, MD, USA (PDF | 150.9k)
  11. May 2007, New evidence for conquering malaria: Operations, Costs and Cost-Effectiveness, Washington, DC, USA (PDF | 220.5k)
  12. Apr 2006, Non-Communicable Diseases, Beijing, China (PDF | 1.0MB)
  13. Jun 2007, Overcoming Challenges of Reproductive Health: The Case For Family Planning, Accra, Ghana (PDF | 319.6k)
  14. Mar 2007, Scaling Up Cost-Effective Interventions And Best Practices; An Overview From DCPP, Arusha, Tanzania (PDF | 366.5k)
  15. Jun 2008, Tuberculosis Disease and Cost Effective Control Strategies In Resource Poor Countries, Juba, Southern Sudan (PDF | 6.1MB)
  16. Oct 2007, What we Know about Effective Adolescent Health Programs, Washington, DC, USA (PDF | 162.8k)

News & Events

News
  1. Jan 18, 2007: Advocating Cost-Effective Interventions for Chronic Diseases
  2. Aug 1, 2007: DCPP Quarterly Newsletter August 07
  3. Mar 16, 2007: Ministers Strive to Scale Up Cost-Effective Interventions
  4. Aug 8, 2007: PAHO Highlights DCPP's 'Best Buys' in 'Perspectives in Health' Magazine
  5. Jan 23, 2009: World Leprosy Day is January 25th, 2009
Events
  1. Apr 2, 2006: Disease Control Priorities Project Launch
  2. Oct 27, 2006: USAID Global Health Mini-University
 

Resources

Related Analysis
  1. Alcohol, Addiction, and Public Health (PDF | 593.7k)
  2. An International Review of Cost-Effectiveness Studies for Mental Disorders (PDF | 810.2k)
  3. An International Review of the Economic Costs of Mental Illness (PDF | 136.3k)
  4. Analyzing Health Equity Using Household Survey Data: A guide to techniques and their implementation (PDF | 3.3MB)
  5. Comparing Quality in Disparate Settings Using Vignettes to Control for Case-Mix Variation (PDF | 428.1k)
  6. Controlling onchocerciasis in sub-Saharan Africa
  7. Controlling trachoma in Morocco
  8. Cost-Effectiveness of a Pediatric Dengue Vaccine (PDF | 252.3k)
  9. DCP2 Tuberculosis Supplementary Material (Chapter 16 Annex) (PDF | 564.2k)
  10. Deaths and Disease Burden by Cause: Global Burden of Disease Estimates for 2001 by World Bank Country Groups (PDF | 1.7MB)
  11. Disease and Mortality in Sub-Saharan Africa, Second Edition (PDF | 5.1MB)
  12. Do Malaria Control Interventions Reach the Poor?: A View Through the Equity Lens (PDF | 1.5MB)
  13. Eliminating measles in southern Africa
  14. Eliminating polio in Latin America and the Caribbean
  15. Eradicating smallpox
  16. Feasibility of Scaling-up Interventions: The Role of Intervention Design (PDF | 744.1k)
  17. Fertility Regulation Behaviors and Their Costs: Contraception and Unintended Pregnancies in Africa and Eastern Europe & Central Asia (PDF | 2.6MB)
  18. Health's Contribution to Economic Growth in an Environment of Partially Endogenous Technical Progress (PDF | 370.0k)
  19. Health-seeking behaviour and the health system response (PDF | 524.2k)
  20. Improving the health of the poor in Mexico
  21. Mental Health and Labor Markets Productivity Loss and Restoration (PDF | 664.5k)
  22. Modeling the Cost Effectiveness of Injury Interventions in Lower and Middle Income Countries: Opportunities and Challenges (PDF | 501.7k)
  23. Optimal Disease Eradication (PDF | 598.7k)
  24. Organisational Relationships and the "Software" of Health Sector Reform (PDF | 394.4k)
  25. Preventing diarrheal deaths in Egypt
  26. Preventing Hib disease in Chile and The Gambia.
  27. Preventing HIV and sexually transmitted infections in Thailand
  28. Public Management and the Essential Public Health Functions (PDF | 312.3k)
  29. Reducing guinea worm in Asia and sub-Saharan Africa
  30. Saving mothers' lives in Sri Lanka
  31. Science and Technology for Disease Control: Past, Present, and Future (PDF | 280.5k)
  32. Soil-Transmitted Helminthic Infections: Updating the Global Picture (PDF | 678.6k)
  33. Stimulating Economic Growth Through Improved Nutrition (PDF | 1.1MB)
  34. Suicide and Suicide Prevention in Developing Countries (PDF | 241.6k)
  35. The Commonwealth Health Ministers Book 2007: Strengthening Health Systems (PDF | 594.3k)
  36. The Cost-Effectiveness of Primary Care Services in Developing Countries: A Review of the International Literature (PDF | 382.2k)
  37. The economic burden of illness for households: A review of cost of illness and coping strategy studies focusing on malaria, tuberculosis and HIV/AIDS (PDF | 771.9k)
  38. The Global Burden of Disease Due to Schistosomiasis (PDF | 346.6k)
  39. The Implications of Technology Change for Health Care Delivery in Sri Lanka (PDF | 188.0k)
  40. Unit Costs of Health Care Inputs in Low and Middle Income Regions (PDF | 1.2MB)
  41. Using Evidence About 'Best Buys' to Advance Global Health (PDF | 395.8k)
  42. Water Supply, Sanitation, and Hygiene Promotion (PDF | 506.3k)
  43. Why Has Infant Mortality Decreased at Such Different Rates in Different Countries? (PDF | 413.5k)
  44. World Development Report 1993: Investing in Health (PDF | 6.1MB)
Fact Sheets
  1. Addiction to Heroin and Other Opiates: Developing Countries Need Strategies to Reduce Harm (PDF | 315.2k)
  2. Cardiovascular Disease (PDF | 470.6k)
  3. Financing Health Systems (PDF | 1.1MB)
  4. Finding the Best Health Buys (PDF | 655.1k)
  5. L'analyse coût-efficacité au service de la définition des priorités de santé (PDF | 289.4k)
  6. Primary Health Care (PDF | 311.5k)
  7. Tax and Spend for Better Health: Often Overlooked, Fiscal Policies Are Powerful Tools (PDF | 297.8k)
  8. The Critical Role of District Hospitals (PDF | 292.2k)
  9. The Scourge of Skin Diseases: Most Can Be Resolved With Cost-Effective Treatments (PDF | 671.4k)
  10. Tobacco Addiction (PDF | 468.2k)
  11. Using Cost-Effectiveness Analysis for Setting Health Priorities (PDF | 276.4k)
  12. Uso del análisis de la eficacia en función del costo para establecer prioridades de salud (PDF | 678.9k)
 

Back to Full List of Topics

QUICK FIND

Find specific content in the three core DCPP publications.




EMAIL UPDATES

Sign up to receive periodic email updates from DCPP

 
© 2006 The World Bank Group, All Rights Reserved.
The World Bank World Health Organization John E. Fogarty International Center Population Reference Bureau NLM Bill & Melinda Gates Foundation